PerturbAI Launches from Stealth, Unveils the World's Largest In Vivo CRISPR Atlas [Yahoo! Finance]
PerturbAI Launches from Stealth, Unveils the World's Largest In Vivo CRISPR Atlas
Life Sciences Tools & Services Stocks Q4 In Review: 10x Genomics (NASDAQ:TXG) Vs Peers [Yahoo! Finance]
10x Genomics (TXG) had its price target raised by Stifel Nicolaus from $20.00 to $25.00. They now have a "buy" rating on the stock.
10x Genomics (NASDAQ:TXG) had its "neutral" rating reaffirmed by analysts at UBS Group AG.